Trial intelligence / Profile preview

Salbutamol vs Placebo in COPD Exacerbation with Noninvasive Ventilation

NCT01958814Phase 2Completed

Sponsor
University Hospital Tours
Start
Feb 2012
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of salbutamol in chronic obstructive pulmonary disease (COPD), sponsored by University Hospital Tours. Started Feb 2012; status: completed.

02

Drugs

salbutamol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01958814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01958814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call